With dual and triple agonists, clinical studies are now achieving results that are otherwise only known from bariatric surgery
Los estudios de resultados cardiovasculares han demostrado que ciertos agonistas GLP-1 (como liraglutida, semaglutida y dulaglutida) reducen significativamente el riesgo de eventos cardiovasculares mayores (infarto de miocardio, accidente cerebrovascular y muerte cardiovascular) en pacientes con diabetes tipo 2 y enfermedad cardiovascular establecida o mltiples factores de riesgo
People with advanced diabetic retinopathy should discuss risks with their doctor, since rapid improvements in blood sugar from any diabetes treatment can temporarily worsen eye disease
Along with choline, it works like a pick axe does to dirt and rock
GSH exerts a negative feedback inhibition on GCL
Known for its role in tissue repair, reducing inflammation, and supporting cellular health, it also promotes skin health by improving skin tone, texture, and firmness, while aiding elastin production for healthy aging